Design, Synthesis, and Biological Evaluation of Quinoxaline Bearing Tetrahydropyridine Derivatives as Anticancer, Antioxidant, and Anti-Tubercular Agents

被引:3
|
作者
Pavale, Ganesh [1 ]
Acharya, Poornima [1 ]
Korgavkar, Nilesh [2 ]
Ramana, M. M. V. [1 ]
机构
[1] Univ Mumbai, Dept Chem, Mumbai 400098, India
[2] Univ Mumbai, Mithibai Coll, Dept Chem, Mumbai, India
关键词
Quinoxaline; tetrahydropyridine; anticancer; antioxidant; anti-mycobacterial; molecular docking; ANTIPROLIFERATIVE ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; CHEMISTRY; ANTIBACTERIAL; ANTIFUNGAL; DIVERSITY; POTENT;
D O I
10.2174/1573409918666220804142753
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Quinoxaline and Tetrahydropyridine derivatives showed various biological properties. The combination of these two scaffolds may contribute to good biological activity and may give novel and efficacious bioactive candidates. Objective: The present study aimed to identify bioactive agents with quinoxaline bearing tetrahydropyridine derivatives possessing anticancer, antioxidant, and anti-tubercular agents. Methods: A series of novel quinoxaline bearing tetrahydropyridine derivatives have been designed and synthesized in good yields. The synthetic protocol involves three-component Povarov reactions of 6-amino quinoxaline, propenyl guaethol, and substituted aldehydes using BF3 center dot OEt2 as catalyst. The newly synthesized molecules were evaluated for their anticancer activity against four cell lines, i.e. A-549, MCF-7, PC-3, and HepG2. Results: The results from in vitro assay indicated that compound 4a proved to be as potent as the standard drug adriamycin against all cell lines with GI50 values <10 mu g/ml. Compounds 4b, 4f, and 4i exhibited good cytotoxicity against A-549 cell line. All synthesized molecules were evaluated for their antioxidant activity and the results revealed that the compounds 4a, 4b, and 4i showed promising antioxidant activities against DPPH and H2O2 scavenging. In addition, the anti-mycobacterial activity of the synthesized compounds against MTB H37Rv strain was determined using the MABA method. The results indicate that the compounds 4a, 4b, 4g, and 4i showed better anti-mycobacterial activity than the standard drugs pyrazinamide, ciprofloxacin and streptomycin with an MIC value of 1.6 mu g/ml. Furthermore, molecular docking studies and ADME properties showed good pharmacokinetic profile and drug-likeness properties. Conclusion: These studies showed that a series of novel quinoxaline bearing tetrahydropyridine derivatives exhibit anticancer, anti-mycobacterial, and antioxidant activities.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 50 条
  • [41] Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives
    Horita, Yasuhiro
    Takii, Takemasa
    Kuroishi, Ryuji
    Chiba, Taku
    Ogawa, Kenji
    Kremer, Laurent
    Sato, Yasuo
    Lee, YooSa
    Hasegawa, Tomohiro
    Onozaki, Kikuo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (03) : 899 - 903
  • [42] Synthesis and Bio-evaluation of GR135486X Derivatives as Potent Anti-Tubercular Agents
    Sangu, Komal G.
    Varakala, Saiprasad Dasugari
    Krishna, Eruva Vamshi
    Akhir, Abdul
    Saxena, Deepanshi
    Ahmad, Mohammad Naiyaz
    Chopra, Sidharth
    Misra, Sunil
    Sriram, Dharmarajan
    Rode, Haridas B.
    CHEMISTRYSELECT, 2023, 8 (01):
  • [43] Synthesis, characterization, and biological evaluation of coumarin-nitric oxide donor hybrids as anti-tubercular agents
    Kareem, Afeez I.
    Malan, Sarel F.
    Kapp, Erika
    Shamido, Sean
    Joubert, Jacques
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 12
  • [44] Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents
    Jadhavar, Pradeep S.
    Dhameliya, Tejas M.
    Vaja, Maulikkumar D.
    Kumar, Dinesh
    Sridevi, Jonnalagadda Padma
    Yogeeswari, Perumal
    Sriram, Dharmarajan
    Chakraborti, Asit K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2663 - 2669
  • [45] Discovery of New Isoniazid Derivatives As Anti-tubercular Agents: In silico Studies, Synthesis, and In vitro Activity Evaluation
    Mohd, Abida Ash
    Imran, Mohd
    Alnaser, Noura Yousif
    Altimyat, Shams Saud
    Al-otaibi, Nawaf M.
    Bawadekji, Abdulhakim
    ORIENTAL JOURNAL OF CHEMISTRY, 2023, 39 (06) : 1510 - 1520
  • [46] Isonicotinoyl-butanoic acid hydrazone derivatives as anti-tubercular agents: In-silico studies, synthesis, spectral characterization and biological evaluation
    Mehak Saba Lone
    Mohamad Mosa Mubarak
    Syed Ayaz Nabi
    Farhat Ramzan Wani
    Shaista Amin
    Sayima Nabi
    Hadiya Amin Kantroo
    Mohammed Samim
    Syed Shafi
    Shamim Ahmad
    Zahoor Ahmad
    Syed Ovais Rizvi
    Kalim Javed
    Medicinal Chemistry Research, 2023, 32 : 808 - 826
  • [47] Isonicotinoyl-butanoic acid hydrazone derivatives as anti-tubercular agents: In-silico studies, synthesis, spectral characterization and biological evaluation
    Lone, Mehak Saba
    Mubarak, Mohamad Mosa
    Nabi, Syed Ayaz
    Wani, Farhat Ramzan
    Amin, Shaista
    Nabi, Sayima
    Kantroo, Hadiya Amin
    Samim, Mohammed
    Shafi, Syed
    Ahmad, Shamim
    Ahmad, Zahoor
    Rizvi, Syed Ovais
    Javed, Kalim
    MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (05) : 808 - 826
  • [48] Design, Synthesis, Evaluation, and Molecular Docking Study of Novel Quinoline Hydrazone Analogues as Anti-Tubercular Agents
    Gupta, Vaibhav
    Sundaramoorthy, Niranjana Sri
    Bhanwala, Neeru
    Ambatwar, Ramesh
    Kumar, Sumit
    Singh, Ramandeep
    Khatik, Gopal L.
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2024, 23 (09): : 1197 - 1208
  • [49] Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action
    Liu, Chun-Xiu
    Zhao, Xin
    Wang, Lei
    Yang, Zai-Chang
    MICROBIAL PATHOGENESIS, 2022, 165
  • [50] An Insight on the Prospect of Quinazoline and Quinazolinone Derivatives as Anti-tubercular Agents
    Kushwaha, Namrata
    Sahu, Adarsh
    Mishra, Jyotika
    Soni, Ankit
    Dorwal, Dhawal
    CURRENT ORGANIC SYNTHESIS, 2023, 20 (08) : 838 - 869